PARATHYROID TUMOUR MALIGNANT

PARATHYROID TUMOUR MALIGNANT was reported 128 times

These drug classes are most commonly taken by patients reporting PARATHYROID TUMOUR MALIGNANT:

# Drug Count
0 RANK Ligand Inhibitor [EPC] 44
1 Kinase Inhibitor [EPC] 18
2 Nucleoside Metabolic Inhibitor [EPC] 16
3 Platinum-based Drug [EPC] 15
4 Topoisomerase Inhibitor [EPC] 15
5 Alkylating Drug [EPC] 14
6 Interferon beta [EPC] 9
7 Nonsteroidal Anti-inflammatory Drug [EPC] 8
8 Corticosteroid [EPC] 6
9 Vitamin C [EPC] 5
10 Calcium [EPC] 4
11 Platelet Aggregation Inhibitor [EPC] 4
12 Vitamin B12 [EPC] 4
13 Vitamin D [EPC] 4
14 Calcium Channel Blocker [EPC] 3
15 Dihydropyridine Calcium Channel Blocker [EPC] 3
16 Loop Diuretic [EPC] 3
17 Potassium Channel Blocker [EPC] 3
18 Vitamin D3 Analog [EPC] 3
19 Angiotensin 2 Receptor Blocker [EPC] 2
20 Benzodiazepine [EPC] 2
21 Central alpha-2 Adrenergic Agonist [EPC] 2
22 Dietary Cholesterol Absorption Inhibitor [EPC] 2
23 Proton Pump Inhibitor [EPC] 2
24 Serotonin and Norepinephrine Reuptake Inhibitor [EPC] 2
25 Thiazide Diuretic [EPC] 2
26 Tumor Necrosis Factor Blocker [EPC] 2
27 Xanthine Oxidase Inhibitor [EPC] 2
28 Aldosterone Antagonist [EPC] 1
29 Anti-IgE [EPC] 1
30 CD20-directed Cytolytic Antibody [EPC] 1
31 Erythropoiesis-stimulating Agent [EPC] 1
32 Expectorant [EPC] 1
33 GLP-1 Receptor Agonist [EPC] 1
34 HMG-CoA Reductase Inhibitor [EPC] 1
35 Insulin Analog [EPC] 1
36 Insulin [EPC] 1
37 Interleukin-12 Antagonist [EPC] 1
38 Interleukin-23 Antagonist [EPC] 1
39 Microtubule Inhibitor [EPC] 1
40 Osmotic Laxative [EPC] 1
41 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1
42 Somatostatin Analog [EPC] 1
43 Sulfonylurea [EPC] 1
44 beta-Adrenergic Blocker [EPC] 1